Continuing the company’s marketing work towards commercialization by igniting interest and awareness in potential customers and collaborators, Lumito will be exhibiting at the European Association for Cancer Research (EACR) 2023 in Torino, Italy 12-15 of June, as well as Nordic Oncology Forum in Stockholm 26-27 of June.
“We look forward to showcasing our product and to continue building valuable relations by being present at these important gatherings. In Stockholm, we’ll meet both new and existing connections in Sweden and the Nordics, which is our first step in our launch strategy, and in Torino we’ll prepare for the rest of Europe. There, it will be aimed towards cancer research, where all new and innovative things will be presented and discussed”, comments CEO Mattias Lundin who will be present with three colleagues in Sales & Marketing.
Lumito’s product SCIZYS is made up of a scanner and UCNP (Upconverting Nano Particles) reagent kit. The aim is to launch the product in the first half of 2023 in research laboratories.
